<DOC>
	<DOCNO>NCT02193100</DOCNO>
	<brief_summary>To characterize metabolism glucose leukemic cell patient leukemia initial chemotherapy . To compare metabolism glucose leukocytes healthy volunteer leukemic cell leukemic patient .</brief_summary>
	<brief_title>Pre Post Treatment Metabolomic Analysis Leukemia : A Translational Clinical Trial Brown Cancer Center</brief_title>
	<detailed_description>To characterize glycolytic metabolism patient demonstrate leukemic cell serum metabolite analysis C13-glucose administration strategic time point treatment . To detect measure 13C-labeled metabolic marker may present serum urine leukemic patient . To characterize glycolytic metabolism patient demonstrate leukemic cell serum metabolite analysis C13-glucose administration strategic time point treatment . To detect measure 13C-labeled metabolic marker may present serum urine leukemic patient .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<criteria>Inclusion Criteria Leukemia Subjects : Each criterion follow section must meet order patient eligible enrollment . Only patient clinically diagnose histologically diagnose leukemia eligible participate nontherapeutic study . All patient must measurable quantity leukemic blast peripheral blood detect CBC . No history diabetes experimental group control group . Patients know hepatitis C HIV ( AIDS ) exclude . Patients must inform investigational nature study sign give write informed consent accordance institutional federal guideline . Inclusion Criteria forHealthy Subjects : Subjects must know prior history cancer malignant blood disorder . Where possible , follow carry verify cancer develop since blood collection . This do phone call perform one month sample ask new medical condition arise . Subjects must WBC , RBC , platelet count within normal range CBC . Subjects know hepatitis C HIV ( AIDS ) exclude . No history Diabetes At least 30 year age Preferably fast 12 hour ( minimum 8 hour ) prior enrollment Patients must inform investigational nature study sign give write informed consent accordance institutional federal guideline . None list protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>